Suppr超能文献

新冠后状况:临床表型、病理生理机制、病理学及管理策略

Post-COVID-19 condition: clinical phenotypes, pathophysiological mechanisms, pathology, and management strategies.

作者信息

Vlaming-van Eijk Larissa E, Tang Guolu, Bourgonje Arno R, den Dunnen Wilfred F A, Hillebrands Jan-Luuk, van Goor Harry

机构信息

Department of Pathology and Medical Biology, Division of Pathology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.

Department of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.

出版信息

J Pathol. 2025 Aug;266(4-5):369-389. doi: 10.1002/path.6443. Epub 2025 Jun 10.

Abstract

Post-COVID-19 condition (PCC), also known as long COVID, is a complex multiple organ system condition that can develop and persist for months after acute COVID-19. PCC encompasses a wide range of symptoms, resulting in heterogeneous clinical manifestations. These manifestations likely arise from diverse underlying pathophysiological mechanisms, which, in turn, are influenced by risk factors such as age, sex, and comorbidities. To this end, characterising clinical phenotypes of PCC is essential for deepening our understanding of its (potentially) distinct pathophysiological mechanisms and for advancing diagnostic and patient-tailored management strategies. PCC is thought to result from a complex interaction of various pathophysiological mechanisms, leading to functional and structural pathological alterations across multiple organ systems. Investigating these alterations is critical to improving our currently incomplete understanding of PCC's complex pathophysiology. This review provides an overview of the main clinical phenotypes of PCC, characterises these phenotypes by examining symptoms and signs, as well as the associated risk factors. The main hypothesised pathophysiological mechanisms are discussed by outlining the current knowledge on PCC pathology, focussing on the most commonly affected organ systems. Current PCC management includes supportive care such as physiotherapy and the repurposing of existing drugs primarily targeting persistence of SARS-CoV-2 (e.g. antivirals, monoclonal antibodies) and immune dysfunction (e.g. antiinflammatory drugs, immunomodulators). To date, prevention of SARS-CoV-2 infection remains critical, which can be achieved through effective public health measures and vaccination strategies. Finally, this review highlights current knowledge gaps and proposes future research directions to advance the understanding and treatment of PCC. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

摘要

新冠后状况(PCC),也称为长新冠,是一种复杂的多器官系统疾病,可在急性新冠感染后数月出现并持续存在。PCC包括广泛的症状,导致临床表现异质性。这些表现可能源于多种潜在的病理生理机制,而这些机制又受到年龄、性别和合并症等风险因素的影响。为此,明确PCC的临床表型对于深化我们对其(潜在)不同病理生理机制的理解以及推进诊断和针对患者的管理策略至关重要。PCC被认为是多种病理生理机制复杂相互作用的结果,导致多个器官系统出现功能和结构病理改变。研究这些改变对于改善我们目前对PCC复杂病理生理学的不完整理解至关重要。本综述概述了PCC的主要临床表型,通过检查症状、体征以及相关风险因素来描述这些表型。通过概述目前关于PCC病理学的知识,重点关注最常受累的器官系统,讨论了主要的假设病理生理机制。目前PCC的管理包括支持性护理,如物理治疗,以及重新利用现有主要针对SARS-CoV-2持续存在(如抗病毒药物、单克隆抗体)和免疫功能障碍(如抗炎药物、免疫调节剂)的药物。迄今为止,预防SARS-CoV-2感染仍然至关重要,这可通过有效的公共卫生措施和疫苗接种策略来实现。最后,本综述强调了当前的知识空白,并提出了未来的研究方向,以推进对PCC的理解和治疗。© 2025作者。《病理学杂志》由约翰·威利父子有限公司代表大不列颠及爱尔兰病理学会出版。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8897/12256391/2fbfcf94d6a0/PATH-266-369-g004.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验